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Introduction
Morbidity and mortality have decreased significantly since the introduction of highly active anti-retroviral therapy (HAART) for treating HIV-infected patients [1,2]. The decline in the incidence of oro pharyngeal candidiasis is thought to be due to immune reconstitution of the host and HIV-protease inhibitors (HIV-PIs) in HAART. HIV-PI has been shown to exert both in vivo and in 
vitro effects on Candida species; in particular, the inhibition of secreted aspartyl proteinase (Sap) secretion [3,4].Saps are encoded by 10 SAP genes and different genes appear to play different roles in C. albicans infections. These genes are involved in adhesion, tissue damage, and evasion of host immune responses [5]. In the pre-HAART era, Candida isolated from HIV-infected patients was found to have higher proteolytic activities [6,7]. Although HIV-PI demonstrates a protective effect against candidal infection, De Bernardis et al. [8] found an increase in Sap production in vitro from sequential isolates of C. albicans from patients on HAART-PIs [8]. Therefore it is considered that other factors may also be involved in decreasing the incidence of oro pharyngeal candidiasis in HIV-infected patients.Besides Saps, other exo enzymes such as phospholipases may also play an important role in the pathogenesis of Candida. Phospholipases are important in catalyzing the hydrolysis of 
phospholipids which are the major components of host cell membranes to thereby facilitate candidal invasion [9]. Seven phospholipase genes (PLA, PLB1, PLB2, PLC1, PLC2, PLC3 and 
PLD1) have been identified [10], of which only four of them (PLB1, PLB2, PLC1 and PLD1) have been well characterized [11-14] Limited studies have been conducted on PLA, PLC2 and PLC3 are not critical for morphogenesis and interaction with macrophages and their roles in pathogenesis have not been fully elucidated [15]. Haemolysin is another putative virulence factor that contributes to candidal pathogenesis. C. albicans have the ability to secrete haemolysin to lyse host erythrocytes and strip iron from hemoglobin molecules, which facilitates hyphal invasion in disseminated candidacies [16]. A partial DNA sequence of HLP also known as putative haemolysin gene, encoding a protein with haemolytic activity in Candida was amplified and cloned [17]. Subsequently Luo G et al. [18] demonstrated the HLP gene expression in C. glabrata, to illustrate the role of HLP gene in haemolysis. To date, only a few studies have reported on the phospholipases and haemolysin activities in HIV-infected individuals. The effect of HAART-PI on C. albicans secretion or activities, and their relations with Saps are still unknown. Therefore, the aims of the present study were to determine the Sap, phospholipase and haemolysin activities of C. albicans isolated from HIV-infected patients on HAART, compare it with a healthy control group and to investigate if there is any 
correlation between the enzyme profiles of C. albicans isolates and patients’ demographic data, stage of HIV infection, risk for HIV, current medications, CD4 counts, HIV viral loads, salivary 
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AbstractThe mortality and morbidity of HIV-infected patients have declined with the advent of highly active antiretroviral therapy (HAART), but its effect on Candida infections remains elusive. The aims of the present study were to determine the effect of HAART on the phosphor lipase, proteinase and haemoltyic activities of oral Candida albicans, and to investigate the correlation between these enzyme profiles and the patients’ demographic and clinical parameters. Isolates were obtained from 16 Chinese HIV-infected patients on HAART and 16 healthy controls using oral rinse technique. The isolates were tested in vitro for phospholipase, proteinase and haemolytic activities using three different plate assays. The phospholipase and haemolytic activities were found to be significantly higher (p <0.05) and the proteinase activities were lower in the test group (p< 0.05). The lower proteinase activities in HIV-infected group could be due to the direct effect of protease inhibitors in HAART while the higher phospholipase and haemolytic activity in the HIV-infected group remains elusive. These finding provide evidence of altered extracellular enzyme activities in the Candida isolates obtained from HIV patients on HAART, which may affect the infectivity of the Candida isolates. 
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pH and history of oral candidiasis.
Materials and Methods Sixteen oral Candida Albicans isolates obtained from HIV-1 infected Chinese patients who were recruited from the Special Medical Services, Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China were used in the study. The inclusion criteria of the patients were HIV-infected and aged 18 years or above who were stabilized under HAART for at least one year. Subjects who had received antifungals or pentamidine during the last six months preceding the examination, those with a history of acute systemic disease, such as fever or diarrhea, and those who were smokers or pregnant were excluded. An equal number of healthy individuals, age and sex matched were to constitute the control group. Ethical Approval was obtained from the Institutional Review Board of the University of Hong Kong and the Kowloon central cluster. Informed consent was obtained prior to study procedures.
A modified protocol for concentrated rinse culture was used to isolate C. albicans from the patients [19]. In brief, patients were given 10 ml phosphate buffered saline (PBS) (0.1M, pH 7.3) in a sterile universal container and instructed to rinse the mouth for 60 s. After the oral rinse was expectorated into the container, the sample was transferred immediately to the laboratory, where it was centrifuged at 1700 g for 10 minutes. The supernatant was discarded and the pellet re suspended in 2 ml PBS on a vortex mixer for 30 s. A spiral plater (Model DU; spiral system) was used to dispense 50 µl of the suspension onto various media, as described below.The concentrated oral rinse was spiral-plated with an Archimedean spiral onto a Sabouraud dextrose agar (SDA) plate (Gibco) and incubated for 48 h at 370C. Well-separated yeast colonies were sub cultured onto SDA plates to obtain pure yeast cultures that were then harvested suspended in water in sterile vials and stored at -200C. All yeast isolates were identified with a commercially available identifying kit system, ID32C (bioMerieux). 
Data collectionDemographic data and information on education level, income and presence of any extra-oral or intra-oral lesion of the patients was gathered using a researcher-administered questionnaire. The HIV-1 viral load, CD4+ cell counts, risk for HIV, HIV staging, current medications and history of oral 
candidiasis were recorded from the medical files.
Determination of phospholipase activity Extracellular phospholipase activity of C. albicans isolates was screened by measuring the size of precipitation zone on egg yolk agar after growth [10]. The medium of egg yolk agar contained of 0.11 g CaCl2, 11.7 g NaCl, 13.0 g SDA (Gibco) and 10% sterile egg yolk (Oxoid) (with in 184 ml distilled water). Initially, the constituents devoid of the egg yolk were mixed and sterilized, followed by egg yolk was centrifuged at 500 g for 10 min at room temperature and addition of 20 ml of the supernatant was done to the sterilized medium. Test and control Candida isolates of standard inoculate (10 ul, with 108 yeast cells per ml saline) were 
deposited onto the egg yolk agar medium and room temperature was used to dry it. Diameter of the precipitation zone around the colony was determined of each culture after their incubation at 370C for 48 h. (phospholipase activity indicator).The Reading of the plates were done using computerized image analysis system (Quantimet 500 Qwin; Leica), that 
measured the diameter of the colonies on a magnified scale relative to the precipitation zones. The ratio of the diameter of the colony to the diameter of the colony plus the precipitation zone (mm) was expressed as Phospholipase activity (PZ value) [20]. Each yeast isolate was tested in duplication on three separate occasions. Positive control used was reference strains of 
C. albicans (ATCC 90028) and Candida glabrata (90030) served as a negative control, from our laboratory stock collection.
Determination of proteinase activityAnalysis of extracellular proteinase activity of C. albicans strains were done in terms of bovine serum albumin (BSA) degradation conferring to the technique described by Staib 
(1965) [21]. In short, a suspension of 1×10⁶ cells ml-1 from 18hrs was prepared, and 1 % BSA plate was used to inoculate 10 µl of suspension. Incubation of plate was done for 5 days at 370C, 
1.25 % naphthalene black solution was flooded for 15 min and washed with 90% (V/V) methanol/water distaining solution. Decolonization for 36 h followed by several changes of distaining solution.The Reading of the plates were done using computerized image analysis system (Quantimet 500 Qwin; Leica), that 
measured the diameter of the colonies on a magnified scale relative to the precipitation zones. The ratio of the diameter of the colony to the diameter of the clear zone of proteolysis (mm) was expressed as Proteinase activity (PrZ value). Each yeast isolate tested in duplication on three separate occasions. Positive control used was reference strains of C. albicans (ATCC 90028) and Candida parapsilosis ATCC 22019 served as a negative control.
Determination of haemolysin activityBlood plate assay was used to evaluate haemolysin activity [22,23]. By adding 7 ml fresh sheep blood (Dixon) to 100 ml 
SDA (Gibco) supplemented with 3 % (w/v) of glucose as a final 
concentration the media was prepared. The final medium pH (mean ± SD) was 5.6 ± 0.2. The medium was deposited with standard inoculum from each of the test and control Candida isolates (10 µl, with 108 yeast cells per ml saline). The plates for 48hrs were incubated at 370C in 5 % CO2.The Reading of the plates were done using computerized image analysis system (Quantimet 500 Qwin; Leica), that 
measured the diameter of the colonies on a magnified scale relative to the precipitation zones. The ratio of the diameter of the colony to the diameter of the clear zone of haemolysis (mm) was expressed as haemolytic activity (Hz value). Each yeast isolate tested in duplication on three separate occasions. Positive control used was reference strains of C. albicans (ATCC 90028) and Candida parapsilosis ATCC 22019 served as a negative control.
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Results and Discussion 
Statistical analysisData were analyzed using statistical analysis computer software (SPSS 15.0 for Windows©, SPSS Inc, U.S.A), and normality tests were carried out using Kolmogorov-Smirnov test. Simple regression was used to analyzePz, PrZ and Hz by thegender, age, education level, income, pH, risk for HIV, CDC, current medications, duration on HAART, oral candidiasis, viral 
load, CD4 count and salivary pH. The level of significance was set at p< 0.05.Colonization and infection by Candida has been shown to have an important economic impact for critically ill patients, in addition to the morbidity and mortality associated with Candida infections in such patients [24].Current study was aimed to investigate the exoenzyme activities of phospholipase, proteinase and haemolysin secreted by C. albicans, isolated from HIV-infected patients on HAART. 
These enzymes were selected because they exhibit specificity towards candidal pathogenesis, particularly by facilitating the hyphal invasion seen in disseminated candidacies [25].
Phospholipase production by C. albicansThe ability of C. albicans to produce phospholipase reflected an important pathogenic feature of this opportunistic fungal pathogen. Candida phospholipases are suspected to act as virulence factors, possibly by facilitating fungal access and adherence to epithelial cells, invasion of the host tissue, and interference with host defense mechanisms [26].Earlier studies have stated phospholipase activity in 30-100% of Candida isolates from various sites [6,20]. In the current study, all 16 isolates in the test group showed phospholipase activities according to plate assay. Our study also showed that HIV positive patients on HAART had increased phospholipase activities compared to HIV negative control group. The Pz value of C. 
albicans isolates range from 0.56 to 0.93 for the test group and 
from 0.72 to 0.88 for the control (Table 1) (p< 0.05). This finding agrees with those from using 239 oral and vaginal C. albicans 
strains from HIV positive patients that showed significantly higher quantities of phospholipase [27]. Others have reported difference in exoenzyme phospholipase activity in Candida from different ecological sites or disease states.
 Table 1:  Phospholipase, proteinase and Haemolysin activities of oral C. albicans isolated from HIV-infected patients on HAART and non-HIV subjects. Results are expressed as mean ±SD.  
Activity HIV-infected group, n=16 Non-HIV group, n=16 Test Statistic p value
Phospholipase(Pz) 0.676±0.107 0.782±0.049 t -3.59 0.001
Proteinase(Prz) 0.641±0.074 0.507±0.144 t 3.31 0.003
Haemolysin(Hz) 0.498±0.023 0.667±0.052 t -11.79 0.000
No significant association was observed between phospholipase activities of C. albicans isolated from the test group and the demographic data, risk for HIV, CDC, current medication, duration on HAART, oral candidiasis, viral load 
and CD4 count. However, there was a significant correlation of the pH value of saliva with the phospholipase activities in the 
test group (R Sq Linear = 0.594), Salivary Ph. Salivary flow rate, wearing dentures, smoking habits and alcohol are some host factors associated with an increased oral carriage rate of Candida species [27]. C. albicans isolates from patients having respiratory 
tract infections produced significantly greater amounts of phospholipase than those from blood was well documented in two recent publications [28,29]. Study by Mukherjee PK, et al. [30] showed that pH changes have an effect on phospholipase mRNA expression [30]. Samaranayake YH et al. [31] also showed that phospholipase gene expression could be affected by the growth conditions [22]. Thus pH changes in the oral niche of HIV-infected patients on HAART may alter the normal PL expression and may explain the altered phospholipase activities observed in the present study. These data in general indicate that the isolation site of C. albicans as well as the disease state of the patient may be an important factor in dictating phospholipase activity.
Proteinase production by C. albicansIn the present study, all of the C. albicans isolates were Sap producers. These results are comparable to the study of [32]. They observed 94.1% of C. albicans isolates from immuno compromised patients are Sap producers. High prevalence of proteolytic activity among C. albicans strains were also reported [2, 33,34].The Prz values in the present study ranged from 0.52 to 0.75 for the test group and from 0.29 to 0.77 for the control group (Table 1). The mean proteinase activity of isolates from the 
test group (0.64±0.07) was significantly lower than that of the control isolates (0.51±0.14) (p< 0.05). One possible explanation for the lower proteinase activities could be the direct effect of proteinase inhibitors of HAART on Sap. Studies by Cassone A et al. & De Bernardis F et al. [8,35] showed the same results, which reported that patients on HAART-PI, but not HAART-non- nucleoside reverse transcriptase inhibitors (NNRTI) strongly inhibited Sap expression [4,8].
No significant association was observed between proteinase activities of C. albicans isolates from HIV infected group and demographic data, saliva pH, risk for HIV, CDC staging, duration on HAART, history of oral candidiasis, viral load and CD4 
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count. However, patients taking abacavir, a nucleoside reverse transcriptase inhibitor (NRTI), were found to have higher proteinase activities compared to the control group (p< 0.05). Since NRTI is not known to have anti-proteinase properties, the reason of the increased proteinase activities remains elusive warrants further investigations. Since proteinase production by Candida especially C. albicans has been shown to depend on various factors, conditions and even stage of infection [36], proteinase assays have been recommended to be interpreted with caution [37].
Haemolysin production by C. albicansSurvival and the ability to establish infection with in the mammalian host by pathogenic organisms depends on the ability to acquire elemental iron [3,38]. Pathogens acquire this iron indirectly from commonly available iron-containing compounds such as hemoglobin, as there is primarily no free iron in human host [39]. For this pathogen uses the enzyme haemolysin which helps to destroys the heme moiety and enables them to extract the elemental iron.Studies on the activity of haemolysin in C. albicans are limited and to the best of our knowledge there are no studies on the activity of haemolysin from oral C. albicans isolated from HIV patients on HAART. In present study, all the C. albicans isolates were haemolysin producers. The Hz values ranged from 0.46 to 0.54 for the HIV infected group and from 0.60 to 0.79 for the control (Table 1). Higher haemolysin activities were detected in the test group (0.50±0.23) than in the control (0.67±0.05) isolate 
(p< 0.05). No significant association was observed between haemolysin activities of C. albicans isolates from test group and gender, age, education level, income, risk for HIV, CDC staging, duration on HAART, history oral candidiasis, viral load and CD4 
count. However, haemolysin activities were significantly lower in patients taking abacavir (p< 0.05). Similarly the action of abacavir on haemolysin is unknown and further investigations 
are warranted to find out how abacavir affects both haemolysin and proteinase activities. The use of PIs ritonavir and lopinavir was also found to be associated with decreased haemolysin activities (p< 0.05). This 
is an interesting finding as the main anti-candidal action of PI is believed to be its action against candidal Sap, this “anti-haemolysin” action may further explain its anti-candidal action. Again, further investigations are warranted.
ConclusionAll three exo enzymes tested were expressed by C. albicans isolates from both the HIV-infected on HAART and control group. 
Significantly, higher phospholipase and haemolysin activities of the C. albicans isolates were seen in the HIV-infected group compared to the control group, whereas the proteinase activity 
was significantly lower in HIV-infected on HAART.Successful oral colonization of C. albicans in HIV-infected on HAART depends on degree of exo enzyme activity. The range of host factors affecting the eco system in which yeast resides controls the qualitative and quantitative variations in expression of array of extracellular enzyme secreted by C. albicans. In order to understand the natural history and host pathogen relationship better, advanced studies on simultaneous expression of C. 
albicans exo enzymes are urgently required.
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